NICOLE MORGAN: Open Payments
NPI 1629637434 · FRAMINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,218 in 157 payments from 20 companies in 2025. Trend: 2023 $2,520 · 2024 $1,770 · 2025 $3,218
Food & beverage: $3,018Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $504 |
| ABBVIE INC. | 34 | $480 |
| Incyte Corporation | 20 | $278 |
| UCB, Inc. | 10 | $259 |
| Lilly USA, LLC | 12 | $217 |
| Amgen Inc. | 7 | $195 |
| Galderma Laboratories, L.P. | 11 | $187 |
| E.R. Squibb & Sons, L.L.C. | 7 | $171 |
| LEO Pharma Inc. | 6 | $163 |
| Regeneron Healthcare Solutions, Inc. | 4 | $120 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, Bimzelx, OTEZLA, Sotyktu, NEMLUVIO.
Industry payments across MA — which companies pay providers there.
